Correlation Between West Pharmaceutical and Carl Zeiss
Can any of the company-specific risk be diversified away by investing in both West Pharmaceutical and Carl Zeiss at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining West Pharmaceutical and Carl Zeiss into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between West Pharmaceutical Services and Carl Zeiss Meditec, you can compare the effects of market volatilities on West Pharmaceutical and Carl Zeiss and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in West Pharmaceutical with a short position of Carl Zeiss. Check out your portfolio center. Please also check ongoing floating volatility patterns of West Pharmaceutical and Carl Zeiss.
Diversification Opportunities for West Pharmaceutical and Carl Zeiss
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between West and Carl is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding West Pharmaceutical Services and Carl Zeiss Meditec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carl Zeiss Meditec and West Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on West Pharmaceutical Services are associated (or correlated) with Carl Zeiss. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carl Zeiss Meditec has no effect on the direction of West Pharmaceutical i.e., West Pharmaceutical and Carl Zeiss go up and down completely randomly.
Pair Corralation between West Pharmaceutical and Carl Zeiss
Considering the 90-day investment horizon West Pharmaceutical Services is expected to generate 0.68 times more return on investment than Carl Zeiss. However, West Pharmaceutical Services is 1.47 times less risky than Carl Zeiss. It trades about 0.0 of its potential returns per unit of risk. Carl Zeiss Meditec is currently generating about -0.12 per unit of risk. If you would invest 35,701 in West Pharmaceutical Services on September 27, 2024 and sell it today you would lose (2,374) from holding West Pharmaceutical Services or give up 6.65% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 99.4% |
Values | Daily Returns |
West Pharmaceutical Services vs. Carl Zeiss Meditec
Performance |
Timeline |
West Pharmaceutical |
Carl Zeiss Meditec |
West Pharmaceutical and Carl Zeiss Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with West Pharmaceutical and Carl Zeiss
The main advantage of trading using opposite West Pharmaceutical and Carl Zeiss positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if West Pharmaceutical position performs unexpectedly, Carl Zeiss can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carl Zeiss will offset losses from the drop in Carl Zeiss' long position.West Pharmaceutical vs. Cigna Corp | West Pharmaceutical vs. Definitive Healthcare Corp | West Pharmaceutical vs. Guardant Health | West Pharmaceutical vs. Laboratory of |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |